Regulatory Update — Week of Nov. 6, 2023

Over the past week, the FDA issued final guidance on real-time oncology review and cosmetic product facility registration and product listing.
Source: Drug Industry Daily

Leave a Comment





This site uses Akismet to reduce spam. Learn how your comment data is processed.